Management of Inoperable Malignant Neoplasms
Advances in Oto-Rhino-Laryngology
|April 20, 2016
Summary
Advanced radiation techniques like neutron and proton therapy show promise for inoperable salivary gland cancers, improving survival rates compared to standard photon radiation therapy.
Area of Science:
- Oncology
- Radiation Oncology
- Medical Physics
Background:
- Inoperable salivary gland malignancy presents treatment challenges with standard photon radiation therapy.
- Current 10-year loco-regional control (LRC) and overall survival rates with photon therapy are approximately 25%.
Purpose of the Study:
- To review the efficacy and toxicity of different radiation modalities for inoperable salivary gland malignancy.
- To explore potential improvements in loco-regional control and survival rates.
Main Methods:
- Review of existing studies on neutron radiation, proton radiation, and stereotactic radiosurgery.
- Comparison of outcomes between different radiation techniques and standard photon therapy.
- Consideration of concurrent chemotherapy and targeted therapies.
Main Results:
- Neutron radiation demonstrated improved 6-year LRC and overall survival (∼60%) but with increased toxicity risks.
- Proton radiation, particularly combined with photons, showed a 90% 5-year LRC for base of skull tumors.
- Stereotactic radiosurgery is utilized as a boost technique for skull base tumors.
Conclusions:
- Neutron and proton radiation offer potential advantages over standard photon therapy for inoperable salivary gland malignancies.
- Further research is needed on concurrent chemotherapy and targeted therapies for these tumors.
- Clinical trial enrollment is encouraged to advance treatment options.